Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SET-IN-STROKE: Phenylephrine-induced hypertension in acute ischemic stroke
NCT01600235Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jun 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of phenylephrine in ischemic stroke, sponsored by Samsung Medical Center. Primary endpoint: NIH Stroke Scale improvement of 2 or more points at 7 days. Status: unknown.
02
Drugs
phenylephrine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01600235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600235.